A Phase III Randomized Trial Of Blinatumomab For Newly Diagnosed Bcr-Abl Negative B Lineage Acute Lymphoblastic Leukemia In Adults
Posted Date: May 15, 2019
- Investigator: Stephen Medlin
- Type of Study: Drug
This study in being done to determine what affects (good and bad) the therapy blinatumomab has on your type of cancer (BCR/ABL negative ALL). This new therapy will be added to what has traditionally been used to treat your specific sub-type of ALL. Studies are being done in ALL and other blood cance
Criteria:
To Qualify For This Study You Must Have Been Recently Diagnosed With A Subtype Of Acute Lymphoblasti
Keywords:
E1910, Leukemia, Negative B Lineage , All, Cancer
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu